ALT5 Sigma (ALTS) Stock Price, News & Analysis

Company Overview

ALT5 Sigma (NASDAQ: ALTS) is a global alternative investment manager specializing in quantitative strategies and risk management solutions for institutional and high-net-worth clients. Since its founding in 2012, the firm has leveraged machine learning, statistical modeling and proprietary data sets to deliver market-neutral, event-driven and macro-oriented investment products. ALT5 Sigma’s platform is built around continuous model refinement, real-time portfolio analytics and adaptive trading algorithms designed to respond to shifting market conditions.

The company’s core offerings include multi‐strategy hedge funds, quantitative overlay services and custom factor‐based portfolios. Its flagship Absolute Return Fund employs a diversified mix of equity, fixed income and derivatives strategies to target consistent risk‐adjusted returns. In addition, ALT5 Sigma provides bespoke risk-optimization tools and white-label quantitative solutions that enable investors to integrate systematic insights into their existing asset allocation frameworks.

Headquartered in New York City, ALT5 Sigma operates regional offices in London and Hong Kong to serve clients across North America, Europe and Asia‐Pacific. The firm maintains relationships with pension funds, endowments, sovereign wealth vehicles and family offices, offering global market access and 24-hour coverage through its centralized trading infrastructure. A dedicated research team monitors macroeconomic trends, geopolitical developments and quantitative efficacy, ensuring that strategies remain aligned with evolving market dynamics.

ALT5 Sigma is led by co-founders and co-chief investment officers Dr. Alan Thompson and Dr. Maria Li, both of whom hold doctoral degrees in financial engineering. Under their guidance, the firm has grown its research capabilities and expanded its intellectual property portfolio to encompass machine learning libraries and proprietary data integration pipelines. Chief Financial Officer Robert Chang oversees corporate finance, reporting and regulatory compliance, while a senior leadership team drives client service, technology development and strategic partnerships.

Key Stats

• Today's Range: $7.27 to $8.07
• 50-Day Range: $6.17 to $10.26
• 52-Week Range: $1.29 to $10.95
• Volume: 214,815 shs
• Average Volume: 238,108 shs
• Market Capitalization: $127.73 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALT5 Sigma Stock Analysis - MarketRank™

ALT5 Sigma scored higher than 0% of companies evaluated by MarketBeat, and ranked 914th out of 915 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for ALT5 Sigma.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

ALT5 Sigma has a P/B Ratio of 14.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.67% of the float of ALT5 Sigma has been sold short.

Short Interest Ratio / Days to Cover

ALT5 Sigma has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in ALT5 Sigma has recently increased by 22.59%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

ALT5 Sigma does not currently pay a dividend.

Dividend Growth

ALT5 Sigma does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.67% of the float of ALT5 Sigma has been sold short.

Short Interest Ratio / Days to Cover

ALT5 Sigma has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in ALT5 Sigma has recently increased by 22.59%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for ALTS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, ALT5 Sigma insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.90% of the stock of ALT5 Sigma is held by insiders.

Percentage Held by Institutions

Only 6.27% of the stock of ALT5 Sigma is held by institutions.

ALTS Stock Analysis - Frequently Asked Questions

How have ALTS shares performed this year?

ALT5 Sigma's stock was trading at $4.65 on January 1st, 2025. Since then, ALTS shares have increased by 57.4% and is now trading at $7.32.

How do I buy shares of ALT5 Sigma?

Shares of ALTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ALT5 Sigma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ALT5 Sigma investors own include JIADE (JDZG), Hyzon Motors (HYZN), New Horizon Aircraft (HOVR), Hour Loop (HOUR), Gossamer Bio (GOSS), Genius Group (GNS) and Ford Motor (F).

Company Calendar

• Today: 7/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: FIN - MISC SVCS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ALTS
• Previous Symbol: NASDAQ:ALTS
• CIK: 862861
• Web: N/A
• Phone: (702) 997-5968
• Fax: 952-930-1800
• Employees: 170
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.24 million
• Net Margins: -38.58%
• Pretax Margin: -53.44%
• Return on Equity: -113.79%
• Return on Assets: -8.96%

Debt

• Debt-to-Equity Ratio: 1.26
• Current Ratio: 0.83
• Quick Ratio: 0.83

Sales & Book Value

• Annual Sales: $12.53 million
• Price / Sales: 10.19
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.49 per share
• Price / Book: 14.94

Miscellaneous

• Outstanding Shares: 17,450,000
• Free Float: 16,600,000
• Market Cap: $127.73 million
• Optionable: N/A
• Beta: 2.21